ArticleGland surgery2026
A simple preoperative nomogram for predicting high-risk parathyroid lesions: a tool to guide surgical strategy in primary hyperparathyroidism.
Article in Gland surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Distinguishing benign from high-risk parathyroid lesions [atypical parathyroid tumor (APT) and parathyroid carcinoma (PC)] preoperatively is crucial for surgical strategy, yet remains difficult in tertiary referral centers confronting an enriched risk profile. This study sought to develop and validate a practical nomogram for individualized risk quantification in this specific clinical context. Methods: We conducted a single-center, retrospective cohort study of patients with biochemically active solitary parathyroid lesions who underwent surgery between January 2009 and May 2024 at Beijing Shijitan Hospital, Capital Medical University. A total of 175 patients were included in the final analysis. A nomogram was developed via multivariable logistic regression and underwent internal validation assessing discrimination, calibration, and clinical utility via decision curve analysis (DCA). Results: Three independent preoperative predictors comprised the final model: age at onset [adjusted odds ratio (aOR) =0.970; 95% confidence interval (CI): 0.944-0.996; P=0.02], serum calcium (aOR =7.233; 95% CI: 2.242-23.333; P=0.001), and parathyroid hormone (PTH) level (aOR =1.001; 95% CI: 1.000-1.002; P=0.03). The nomogram showed good discrimination [area under the receiver operating characteristic curve (AUC) =0.805; 95% CI: 0.730-0.880], satisfactory calibration (Hosmer-Lemeshow P=0.75), and yielded a positive net clinical benefit across threshold probabilities of 5-40%. Conclusions: This preoperative nomogram effectively quantifies individual risk for high-risk parathyroid lesions. Designed for specialized, high-prevalence settings, it offers surgeons an evidence-based metric to inform initial surgical planning and to stratify patients for tailored operative approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.